IBRANCE: Breast cancer simulation
The Ibrance Simulator is a Promotion resource, used by Pfizer Oncology Healthcare Development Managers, that will be used in Ibrance Promotional conversations.
Discrete event simulation is an effective form of scenario generation and engagement around service transformation for healthcare. It can be used to model hospital departments, pathways or entire health economies in an animated and compelling manner.
Simulations are communication tools. They open debate, they enable conversations and engender close working with hospitals and wider healthcare commissioning towards all round healthcare improvements.
The objective of the Ibrance simulation model is to demonstrate, to NHS stakeholders, the benefits of adopting Ibrance for the treatment of ER +ve, HER2 -ve patients with advanced breast cancer in the following key points:
- Firstly the freeing of capacity in the chemotherapy clinic and cost savings by adopting Ibrance to delay disease progression and chemotherapy treatment.
- Secondly, further Service optimisation by moving away from a consultant led or secondary care led service where appropriate.
The results from all scenarios can be exported into a results summary and, on request, the Results Summary Document and Data Analytics resource, can be provided to Healthcare Professions (HCPs) directly from the resource.
How could IBRANCE make a difference to your service capacity and Optimisation ?
PP-IBR-GBR-2225. February 2020